Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6140950 | 6969930 | I | 6140950-1 | 20090122 | 20090318 | 20090331 | EXP | A-JP2009-23968 | ACTELION PHARMACEUTICALS US, INC. | 56 | YR | F | N | 67 | KG | 20090330 | JAPAN |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6140950 | 1011367851 | PS | TRACLEER | 1 | ORAL | 62.5 MG, QD, ORAL | Y | D | 21290 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6140950 | 1011367851 | PULMONARY ARTERIAL HYPERTENSION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6140950 | HO |
| 6140950 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6140950 | CONDITION AGGRAVATED |
| 6140950 | INFECTION SUSCEPTIBILITY INCREASED |
| 6140950 | PLATELET COUNT DECREASED |
| 6140950 | WHITE BLOOD CELL COUNT DECREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6140950 | FGN |
| 6140950 | HP |
| 6140950 | OTH |
| 6140950 | SDY |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6140950 | 1011367851 | 20090116 | 20090122 |